Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/2005
10/20/2005CA2557850A1 Methods of treatment using eszopiclone
10/19/2005EP1586571A1 Dipeptidyl peptidase inhibitors
10/19/2005EP1586564A1 8-azaprostaglandin derivatives and medicinal uses thereof
10/19/2005EP1586322A2 Compositions for inhibition of anglogenesis
10/19/2005EP1585713A1 New stilbene derivatives and their use as aryl hydrocarbon receptor ligand antagonists
10/19/2005EP1585526A2 Novel use of mifepristone and derivatives thereof as hedgehog protein signalling pathway modulators and applications of same
10/19/2005EP1585503A2 Improved oral delivery of peptides
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005EP1404656B9 Benzimidazole derivatives for treating microglia-activation associated diseases such as inflammatory, allergic, infectious or autoimmune diseases
10/19/2005EP1397170B1 Safety shield system for prefilled syringes
10/19/2005EP1370554B1 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
10/19/2005EP1311263B1 Fused pyrrolocarbazoles against inflammation
10/19/2005EP1292340B1 Transfection system
10/19/2005EP1255740B1 Substituted arylpyrazines
10/19/2005EP1237539B1 Oral solution containing galanthamine and a sweetening agent
10/19/2005EP1165061B1 Use of compound preparation made of vitamin d metabolites or vitamin d analogues and partial estrogen agonists for treating osteoporosis
10/19/2005CN1684959A 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-KIT inhibitors
10/19/2005CN1684957A Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
10/19/2005CN1684953A 吡唑化合物 Pyrazole compounds
10/19/2005CN1684952A Novel piperidine derivatives for use in the treatment of chemokine mediated disease states
10/19/2005CN1684708A Anti-NGF antibodies for the treatment of various disorders
10/19/2005CN1684702A Method of treating tumors
10/19/2005CN1684673A Electrospun amorphous pharmaceutical compositions
10/19/2005CN1684594A Fruit and/or vegetable derived composition
10/19/2005CN1683385A Ibuprofen sugar derivative and its preparing process and use
10/19/2005CN1683381A Trifolium pratense extract and preparing method
10/19/2005CN1683017A Heating induction method for local expression of anti-inflammation gene
10/19/2005CN1683008A Collagen polypeptide preparation for supplementing calcium and its preparing method
10/19/2005CN1683001A Chinese medicine for treating gout
10/19/2005CN1682993A Proliferation removing bone penetration formulation
10/19/2005CN1682990A Medicinal preparation for treating rheumatism and rheumatoid diseases
10/19/2005CN1682961A Adhesive plaster for treating prolapse of lumber intervertebral disc and its producing process
10/19/2005CN1682960A Gujinsa capsule and its preparing process
10/19/2005CN1682947A Bone setting paste and its preparing method
10/19/2005CN1682927A Decumbent corydalis tuber freeze-dried powder injection and its preparing method
10/19/2005CN1682914A Capsule for treating arthralgia-syndrome
10/19/2005CN1682901A Cervical vertebrae drawing medicine bag
10/19/2005CN1682900A Chinese medicine preparation for treating psoriasis
10/19/2005CN1682898A Extenral application medicine formulation for treating cervical spondylopathy
10/19/2005CN1682883A Sarcandra solid dispersion and its preparing method
10/19/2005CN1682866A Pure Chinese medicine original medicinal pad for diminishing inflammation, relieving pain and dissipating mass
10/19/2005CN1682860A Medicine for treating osteoporosis and improving bone fracture healing
10/19/2005CN1682835A Preparation of medicine preparation of orthopedics department and its use
10/19/2005CN1682823A Compound drynaria rhizome preparation and its preparing method
10/19/2005CN1682815A Gentongping dripping pill for treating wind-cold channel blocking and its preparing method
10/19/2005CN1682811A Strengthening spine and bone pill ofr treating rigid spondylitis
10/19/2005CN1682793A Medicine composition for treating prolapse of lumber intervertebral disc
10/19/2005CN1682788A Shutongfang for killing pain and its preparation and use
10/19/2005CN1682786A Adhesive plaster
10/19/2005CN1682784A Traumatic injury safflower medicinal preparation
10/19/2005CN1682764A Bone strengthening oral liquor and its preparing method
10/19/2005CN1682748A Chinese medicine preparation for treating rheumatism and preparation and use
10/19/2005CN1682744A Method for preparing asiaticoside cataplasm
10/19/2005CN1682742A Use of 23-hydroxy betulic acid in inhibiting blood vessel formation
10/19/2005CN1682712A Medicinal composition for treating bone metabolic disease
10/19/2005CN1682710A Water soluble soybean aglycone medicinal composition and its preparing method
10/19/2005CN1682705A Skin plaster containing aceclofenac
10/19/2005CN1223591C Piperazine oxime derivatives having Nk-1 receptor antagonistic activity
10/19/2005CN1223369C Hyperosteogeny medicine and preparing method thereof
10/19/2005CN1223346C Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents
10/18/2005US6956052 treatment of cancer and inflammation-associated disorders, such as arthritis; for example,1-[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide
10/18/2005US6956050 Imidazole compounds as anti-inflammatory and analgesic agents
10/18/2005US6956045 Anticancer agents; antiallergens; immunology diseases; antiinflamamtory agents
10/18/2005US6956042 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
10/18/2005US6956037 Benzamide derivatives for the treatment of diseases mediated by cytokines
10/18/2005US6955898 Targeting pharmaceutical agents to injured tissues
10/18/2005US6955810 Method for the treatment of inflammatory disorders
10/18/2005CA2340138C 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/18/2005CA2339273C Branched alkyl pyrrolidine-3-carboxylic acids
10/18/2005CA2334702C Pharmaceutical compositions and uses for androst-5-ene-3.beta.,17.beta.-diol
10/18/2005CA2294171C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
10/13/2005WO2005095587A1 Process for producing somatic stem cell differentiated from embryonic stem cell and use of the same
10/13/2005WO2005095464A1 Hyaluronic acid/methotrexate compound
10/13/2005WO2005095443A1 Drug delivery system using peptide modification
10/13/2005WO2005095381A1 Dipeptidyl peptidase inhibitors
10/13/2005WO2005095375A1 Extract of sophora flavescens flavonoids and uses thereof
10/13/2005WO2005095373A1 Naphthalene derivative, medicinal composition containing the same, and medicinal use thereof
10/13/2005WO2005095372A1 Naphthalene derivative, medicinal composition containing the same, and medicinal use thereof
10/13/2005WO2005094890A1 Composition for increasing body height
10/13/2005WO2005094889A1 Remedy or preventive for arthritis
10/13/2005WO2005094888A1 Damaged tissue therapeutic agent and therapeutic method
10/13/2005WO2005094885A1 Preventive and/or therapeutic agent for disease accompanied by chronic muscle/skeleton pain
10/13/2005WO2005094881A1 Antibody drug
10/13/2005WO2005094856A1 Preparation and therapeutic uses of plants and plant extracts in the hylocereus genus
10/13/2005WO2005094823A1 Flt-3 INHIBITOR
10/13/2005US20050229264 Recombinant gelatins
10/13/2005US20050228170 B7-like molecules and uses thereof
10/13/2005US20050228055 Substituted nitrobenzene derivatives as pharmaceutical and other uses athereof
10/13/2005US20050228042 Statin-like compounds
10/13/2005US20050228036 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
10/13/2005US20050228018 Chemical compounds
10/13/2005US20050228011 use of carboxy-functional benzofurans or benzothiophenes to treat tumor growth, metastasis, osteoporosis, restenosis, inflammation, macular degeneration, diabetic retinopathy, rheumatoid arthritis, and sickle cell anemia; greater bioavailability or fewer side-effects
10/13/2005US20050228005 Protein kinase inhibitors and uses thereof
10/13/2005US20050227997 Selective inhibition of aggrecanase in osteoarthritis treatment
10/13/2005US20050227994 Decomposition inhibitor for extracellular matrix of cartilage
10/13/2005US20050227988 compounds capable of inhibiting, modulating and/or regulating signal transduction of both receptor-type and non-receptor type tyrosine kinases; gliomas, meningomas, cancers, Hodgkin's disease, retinal vascularization; core structure that comprises a benzazocine moiety
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050227983 Triazine compounds and their analogs, compositions, and methods
10/13/2005US20050227973 Human adam-10 inhibitors
10/13/2005US20050227963 Antiinflammatory agents
1 ... 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 ... 820